Two Systemic Barriers Blocking Access to Cutting-Edge Medical Technologies

Two Systemic Barriers Blocking Access

Medical innovation outpaces medical policy with health insurance plans. That reality can be difficult to accept for companies that have poured significant investment into a new device, drug, or biologic. For health plans, FDA marketing authorization is important, but other factors are essential: long-term data, medical society guidelines, provider utilization, etc. Until those factors are […]